The Liquid Embolic Agent Market is experiencing robust growth as healthcare providers increasingly adopt minimally invasive treatment techniques for vascular disorders, neurovascular diseases, and cancer-related conditions. The growing incidence of intracranial aneurysms, arteriovenous malformations (AVMs), hypervascular tumors, and traumatic hemorrhage has accelerated the demand for advanced...